Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Efstathiou

Showing results (161-170 of 273) with videos related to

Pageof 28
Sort By:
European Urology|September 30, 2019
Quality Indicators for Bladder Cancer Services: A Collaborative ReviewJeffrey J Leow, James W F Catto, Jason A Efstathiou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2015
Establishing and Delivering Quality Radiation Therapy in Resource-Constrained Settings: The Story of BotswanaJason A Efstathiou, Magda Heunis, Talkmore Karumekayi, et al.
Seminars in Radiation Oncology|June 14, 2025
The Evolving Management of Radiorecurrent Prostate CancerJacob Pozin, Menal Bhandari, Luca Valle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09Anthony L Zietman, Kyounghwa Bae, Jerry D Slater, et al.
NPJ Precision Oncology|December 1, 2025
Androgen receptor splice variant expression and prostate cancer recurrence after salvage therapyDavid J Konieczkowski, Keisuke Otani, Zoe Guan, et al.
Urologic Oncology|May 8, 2019
The current state of randomized clinical trial evidence for prostate brachytherapyRobert T Dess, Payal D Soni, William C Jackson, et al.
Oncogene|March 8, 2018
PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53Qi Liu, Liliana Gheorghiu, Michael Drumm, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
Clinical-pathologic stage discrepancy in bladder cancer patients treated with radical cystectomy: results from the national cancer data basePhillip J Gray, Chun Chieh Lin, Ahmedin Jemal, et al.
European Urology Oncology|May 21, 2021
Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical ProstatectomyShauna R Campbell, Martin C Tom, Shree Agrawal, et al.
Urologic Oncology|May 19, 2023
Impact of a negative confirmatory biopsy on risk of disease progression among men on active surveillance for prostate cancerKeyan Salari, Jason Kowitz, Jeffrey Twum-Ampofo, et al.
Pageof 28

Showing results (161-170 of 273) with videos related to

Sort By:
Pageof 28
European Urology|September 30, 2019
Quality Indicators for Bladder Cancer Services: A Collaborative ReviewJeffrey J Leow, James W F Catto, Jason A Efstathiou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2015
Establishing and Delivering Quality Radiation Therapy in Resource-Constrained Settings: The Story of BotswanaJason A Efstathiou, Magda Heunis, Talkmore Karumekayi, et al.
Seminars in Radiation Oncology|June 14, 2025
The Evolving Management of Radiorecurrent Prostate CancerJacob Pozin, Menal Bhandari, Luca Valle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09Anthony L Zietman, Kyounghwa Bae, Jerry D Slater, et al.
NPJ Precision Oncology|December 1, 2025
Androgen receptor splice variant expression and prostate cancer recurrence after salvage therapyDavid J Konieczkowski, Keisuke Otani, Zoe Guan, et al.
Urologic Oncology|May 8, 2019
The current state of randomized clinical trial evidence for prostate brachytherapyRobert T Dess, Payal D Soni, William C Jackson, et al.
Oncogene|March 8, 2018
PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53Qi Liu, Liliana Gheorghiu, Michael Drumm, et al.
International Journal of Radiation Oncology, Biology, Physics|March 26, 2014
Clinical-pathologic stage discrepancy in bladder cancer patients treated with radical cystectomy: results from the national cancer data basePhillip J Gray, Chun Chieh Lin, Ahmedin Jemal, et al.
European Urology Oncology|May 21, 2021
Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical ProstatectomyShauna R Campbell, Martin C Tom, Shree Agrawal, et al.
Urologic Oncology|May 19, 2023
Impact of a negative confirmatory biopsy on risk of disease progression among men on active surveillance for prostate cancerKeyan Salari, Jason Kowitz, Jeffrey Twum-Ampofo, et al.
Pageof 28